Loading…
The company announced the registration and launch today.
Sonoma Pharmaceuticals, Inc. announced today the registration of its acne products in the UK and their launch in a prominent U.K. pharmacy chain. The registration and launch are part of the company's strategy to expand its market presence in Europe.
No financial figures or share considerations were disclosed in the announcement. The company has a free float of 1,680,100 shares.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.